JPRN-C000000157已完成3 期
Phase III Randomized Study of Induction Therapy Comparing Daunorubicin With Idarubicin Followed By Consolidation Therapy Comparing High-Dose Cytarabine With Sequential Multiagent Chemotherapy in Patients With Previously Untreated De Novo Acute Myeloid Leukemia (JALSG AML201 Study) - Randomized Study of Induction and Consolidation Therapy in Patients With Previously Untreated AML (JALSG AML201 Study)
适应症
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 入组人数
- 850
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 15years-old 至 65years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1.Atypical leukemia 2.History of MDS 3.History of cancer chemotherapy 4.Other active neoplasms 5.Recent history of myocardial infarction or renal failure, 6.Severe comorbidity (diabetes mellitus, infection or liver cirrhosis) 7.Psychological disorders 8.Pregnant and/or lactating woman 9.Positive anti-HIV antibody
研究者
相似试验
招募中
不适用
Randomized controlled trial of induction therapy for thoracic esophageal cancer invading aorta or trahceathoracic esophageal cancerJPRN-UMIN000014718Osaka Medical Center for Cancer and Cardiovascular Diseases160
招募中
3 期
A phase 3 randomized, double-blind study of induction (Daunorubicin/Cytarabine) and consolidation (high-dose Cytarabine) chemotherapy + Midostaurin (PKC412) (IND# 101261) or placebo in newly diagnosed patients < 60 years of age with FLT3 mutated Acute Myeloid Leukemia (AML)Acute Myeloid LeukemiaNL-OMON32771ovartis12
进行中（未招募）
不适用
Randomized three arm phase III trial on induction treatment with a fluoropyrimidine-, oxaliplatin- and bevacizumab-based chemotherapy for 24 weeks followed by maintenance treatment with a fluoropyrimidine and bevacizumab vs. bevacizumab alone vs. no maintenance treatment and reinduction in case of progression for first-line treatment of patients with metastatic colorectal cancer - Optimal Maintenance Therapy with bevacizumab after Induction in metastatic CRCHistologically confirmed and inoperable or irresectable metastatic colorectal cancer (stage IV)MedDRA version: 14.1Level: LLTClassification code 10052362Term: Metastatic colorectal cancerSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 14.1Level: PTClassification code 10010035Term: Colorectal cancer stage IVSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2008-007974-39-DEAIO-Studien-gGmbH
已完成
3 期
A randomized phase III trial of adjuvant therapy with locoregional IFN-beta versus observation in stage II/III cutaneous melanoma (JCOG1309, J-FERON Trial)Cutaneous melanomaJPRN-UMIN000017494Japan Clinical Oncology Group (JCOG)240
已完成
不适用
A randomised phase III study comparing induction chemotherapy to daily low dose Cisplatin both combined with high dose radiotherapy in patients with inoperable non-small cell lung cancer stage I, II and IIIung cancerMalignant neoplasm of bronchus or lungCancerISRCTN73271276etherlands Cancer Institute, Antoni van Leeuwenhoek Hospital (NKI/AVL) and Academic Medical Centre (AMC) (Netherlands)100